Jbpos-0101

Jbpos-0101

SCHEMBL3437166

CC(OC(N)=O)C(O)c1ccccc1Cl

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CXCL8 P10145 2/20 0.41
CASP1 P29466 1/20 0.41
ADRB2 P07550 2/20 0.41
ADRB1 P08588 2/20 0.41
AOC3 Q16853 1/20 0.41
LPAR1 Q92633 2/20 0.38
IDO1 P14902 2/20 0.37
TDO2 P48775 2/20 0.37
IDO2 Q6ZQW0 2/20 0.37
CYP2D6 P10635 2/20 0.36
NFKB1 P19838 2/20 0.36
HIF1A Q16665 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
PNMT P11086 1/20 0.36
NISCH Q9Y2I1 1/20 0.36
BLM P54132 1/20 0.36
ALOX5 P09917 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Jbpos-0101 SCHEMBL3435025 1.00 CXCL8 (0.41) CXCL8CASP1ADRB2ADRB1AOC3
Jbpos-0101 SCHEMBL3437169 1.00 CXCL8 (0.41) CXCL8CASP1ADRB2ADRB1AOC3
Jbpos-0101 SCHEMBL29982650 1.00 CXCL8 (0.41) CXCL8CASP1ADRB2ADRB1AOC3
Jbpos-0101 SCHEMBL3435524 1.00 CXCL8 (0.41) CXCL8CASP1ADRB2ADRB1AOC3
Jbpos-0101 SCHEMBL3437156 1.00 CXCL8 (0.41) CXCL8CASP1ADRB2ADRB1AOC3
SCHEMBL3434807 0.88 CYP1A2 (0.49) CXCL8CASP1IDO1TDO2CYP2D6
SCHEMBL3436024 0.88 CYP1A2 (0.49) CXCL8CASP1IDO1TDO2CYP2D6
SCHEMBL3435796 0.88 CYP1A2 (0.49) CXCL8CASP1IDO1TDO2CYP2D6
SCHEMBL26242470 0.85 CASP1 (0.42) CXCL8CASP1ADRB2ADRB1AOC3
SCHEMBL3436172 0.84 AOC3 (0.42) CXCL8CASP1ADRB2ADRB1AOC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2968211-B1 PHENYL ALKYL CARBAMATE COMPOUNDS FOR USE IN PREVENTING OR TREATING EPILEPSY OR EPILEPSY-RELATED SYNDROME BIO PHARM SOLUTIONS CO LTD (KR) 2021-05-12 EP disclosed
US-10525030-B2 Phenyl carbamate compound and a composition for neuroprotection comprising the same BIO-PHARM SOLUTIONS CO., LTD. (KR) 2020-01-07 US disclosed
US-9956197-B2 Phenyl carbamate compounds for use in preventing or treating pediatric epilepsy and epilepsy-related syndromes BIO-PHARM SOLUTIONS CO., LTD. (KR) 2018-05-01 US disclosed
US-9956197-B2 Phenyl carbamate compounds for use in preventing or treating pediatric epilepsy and epilepsy-related syndromes BIO-PHARM SOLUTIONS CO., LTD. (KR) 2018-05-01 US disclosed
US-9907776-B2 Phenyl carbamate compound and a composition for preventing or treating a psychiatric disorder comprising the same BIO-PHARM SOLUTIONS, CO., LTD. (KR) 2018-03-06 US disclosed
US-9907776-B2 Phenyl carbamate compound and a composition for preventing or treating a psychiatric disorder comprising the same BIO-PHARM SOLUTIONS, CO., LTD. (KR) 2018-03-06 US disclosed
US-9872847-B2 Phenyl carbamate compounds for use in preventing or treating a movement disorder BIO-PHARM SOLUTIONS CO., LTD. (KR) 2018-01-23 US disclosed
US-9872847-B2 Phenyl carbamate compounds for use in preventing or treating a movement disorder BIO-PHARM SOLUTIONS CO., LTD. (KR) 2018-01-23 US disclosed
EP-2527314-B1 Process for preparation of phenyl carbamate derivatives BIO-PHARM SOLUTIONS CO LTD (KR) 2017-10-04 EP disclosed
EP-2797878-B1 PHENYL CARBAMATE COMPOUNDS FOR USE IN PREVENTING OR TREATING STROKE BIO-PHARM SOLUTIONS CO LTD (KR) 2017-08-16 EP disclosed
US-20130165409-A1 PHENYL CARBAMATE COMPOUNDS FOR USE IN ALLEVIATING OR TREATING PAIN BIO-PHARM SOLUTIONS CO., LTD. (KR) 2013-06-27 US disclosed
US-20130165409-A1 PHENYL CARBAMATE COMPOUNDS FOR USE IN ALLEVIATING OR TREATING PAIN BIO-PHARM SOLUTIONS CO., LTD. (KR) 2013-06-27 US disclosed
US-20130165509-A1 PHENYL ALKYL CARBAMATE DERIVATIVE COMPOUND AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME BIO-PHARM SOLUTIONS CO., LTD. (KR) 2013-06-27 US disclosed
US-20130165509-A1 PHENYL ALKYL CARBAMATE DERIVATIVE COMPOUND AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME BIO-PHARM SOLUTIONS CO., LTD. (KR) 2013-06-27 US disclosed
US-20130005801-A1 PHENYLCARBAMATE COMPOUND AND MUSCLE RELAXANT CONTAINING THE SAME BIO-PHARM SOLUTIONS CO., LTD. (KR) 2013-01-03 US disclosed
US-20130005801-A1 PHENYLCARBAMATE COMPOUND AND MUSCLE RELAXANT CONTAINING THE SAME BIO-PHARM SOLUTIONS CO., LTD. (KR) 2013-01-03 US disclosed
US-20120184762-A1 PROCESS FOR PREPARATION OF PHENYL CARBAMATE DERIVATIVES BIO-PHARM SOLUTIONS CO., LTD. (KR) 2012-07-19 US disclosed
US-20120184762-A1 PROCESS FOR PREPARATION OF PHENYL CARBAMATE DERIVATIVES BIO-PHARM SOLUTIONS CO., LTD. (KR) 2012-07-19 US disclosed
WO-2012096458-A2 PROCESS FOR PREPARATION OF PHENYL CARBAMATE DERIVATIVES BIO-PHARM SOLUTIONS CO., LTD. (KR) 2012-07-19 WO disclosed
WO-2012002773-A2 PHENYLCARBAMATE COMPOUND AND MUSCLE RELAXANT CONTAINING THE SAME BIO-PHARM SOLUTIONS CO., LTD. (KR) 2012-01-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130165409-A1 PHENYL CARBAMATE COMPOUNDS FOR USE IN ALLEVIATING OR TREATING PAIN ACHE, HDAC3, TRPV1 CXCL8 937/4885CASP1 459/4885ADRB2 3081/4885
US-20130005801-A1 PHENYLCARBAMATE COMPOUND AND MUSCLE RELAXANT CONTAINING THE SAME CPT1B, MYLK, PYGM CXCL8 4711/4885CASP1 1756/4885ADRB2 183/4885
US-10525030-B2 Phenyl carbamate compound and a composition for neuroprotection comprising the same CHAT, BAX, CASP3 CXCL8 3198/4885CASP1 24/4885ADRB2 3595/4885
US-20130165509-A1 PHENYL ALKYL CARBAMATE DERIVATIVE COMPOUND AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME MYLK, PDE3A, TNNC1 CXCL8 3386/4885CASP1 2375/4885ADRB2 864/4885
US-20120184762-A1 PROCESS FOR PREPARATION OF PHENYL CARBAMATE DERIVATIVES CPS1, BCHE, ACHE CXCL8 4740/4885CASP1 643/4885ADRB2 4106/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.